Condition
EGFR Gene Overexpression clinical trials and research
As of November 12, 2026, Find a Trial lists 2 EGFR Gene Overexpression clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Becotatug Vedotin Plus Pucotenlimab in EGFR-High Advanced Cancers
This phase II study tests whether combining Becotatug Vedotin with Pucotenlimab helps people whose advanced solid tumors express high EGFR.
-
Treatment of newly diagnosed glioblastoma using targeted drug infusion
This study is testing a new way to deliver a targeted drug directly to the brain tumor in people with newly diagnosed glioblastoma to see if it can improve their treatment outcomes.
Related topics
Quick answers
How many EGFR Gene Overexpression clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.